Home › Cancer (all types) › Georgia › Augusta
Cancer (all types) clinical trials in Augusta, GA
7 studies for Cancer (all types) are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
- Quetzal Site 13, Augusta
Visugromab in Cachexia International Trial
RecruitingPhase 2/3
- Augusta University Medical Center, Augusta
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Augusta University Medical Center, Augusta
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Augusta University Medical Center, Augusta
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RecruitingPhase 1/2
- Georgia Cancer Center, Augusta
Galleri® in the Medicare Population.
RecruitingHealthy volunteers welcome
- HCA Healthcare Doctors Hospital, Augusta
Caris Biorepository Research Protocol
RecruitingObservational studyHealthy volunteers welcome
- Augusta University Research Institute, Augusta
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Durham, NC58 studies
- Washington, DC58 studies
- Chicago, IL51 studies
- Seattle, WA49 studies
- Atlanta, GA49 studies
- Arlington, VA48 studies
Other studies in Augusta
- Acute Myeloid Leukemia10 studies
- Ovarian Cancer8 studies
- Endometrial Cancer7 studies
- Sickle Cell Disease5 studies
- Breast Cancer5 studies
- Myasthenia Gravis4 studies
- Blood Cancers4 studies
- Burkitt Lymphoma4 studies
- Diffuse Large B-Cell Lymphoma4 studies
- Chronic Myeloid Leukemia4 studies
- Non-Hodgkin Lymphoma4 studies
- Cervical Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.